Pemafibrate
Drug / Medication
A new selective p-par alpha receptor modulator (SPPARM) fibrate currently undergoing large outcome clinical trials.
Mentioned in 2 videos
Save the 2 videos on Pemafibrate to your own pod.
Sign up free to keep building your knowledge base on Pemafibrate as more episodes are added.
Videos Mentioning Pemafibrate
#129 - Tom Dayspring, M.D.: The latest insights into cardiovascular disease and lipidology
Peter Attia MD
A new selective p-par alpha receptor modulator (SPPARM) fibrate currently undergoing large outcome clinical trials.
407 ‒ Preventing cardiovascular and Alzheimer’s disease: lowering LDL early, APOE4, and more
Peter Attia MD
A fibrate used in the PROMINENT study, which failed to show cardiovascular benefit in a triglyceride-lowering trial.